ADVERSARIAL DRUG DISCOVERY
• PROTEOMICS
• LONGEVITY
• SYNBIO
• CAMBRIDGE
• VENTURE
• INVESTMENT
• BIOSCIENCE
• AI
• ML
• CODE
• DATA PIPELINES
• BIOTECH FUNDING
• DEEP TECH
• ADVANCING SCIENCE
• EPISODES
ABOUT
Hosted by Roy Kurtzbard. PhD Candidate at the University of Cambridge.
Researcher in computational biology and aging. Exploring the intersection of deep tech and venture capital.
The Biotech Thesis was born from a simple observation: the most transformative biotech companies in Europe are being built in Cambridge, yet their stories rarely get told with the depth they deserve.
Each episode brings you face-to-face with the founders, scientists, and investors shaping the future of healthcare from the heart of the Silicon Fen.
The Biotech Thesis was born from a simple observation: the most transformative biotech companies in Europe are being built in Cambridge, yet their stories rarely get told with the depth they deserve.
